The Case for a Smoker's License
Background to the debate:
Tobacco continues to kill millions of people around the world each year and its use is increasing in some countries, which makes the need for new, creative, and radical efforts to achieve the tobacco control endgame vitally important. One such effort is discussed in this PLOS Medicine Debate, where Simon Chapman presents his proposal for a “smoker's license” and Jeff Collin argues against. Chapman sets out a case for introducing a smart card license for smokers designed to limit access to tobacco products and encourage cessation. Key elements of the smoker's license include smokers setting daily limits, financial incentives for permanent license surrender, and a test of health risk knowledge for commencing smokers. Collin argues against the proposal, saying that it would shift focus away from the real vector of the epidemic—the tobacco industry—and that by focusing on individuals it would censure victims, increase stigmatization of smokers, and marginalize the poor.
Vyšlo v časopise:
The Case for a Smoker's License. PLoS Med 9(11): e32767. doi:10.1371/journal.pmed.1001342
Kategorie:
The PLoS Medicine Debate
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001342
Souhrn
Background to the debate:
Tobacco continues to kill millions of people around the world each year and its use is increasing in some countries, which makes the need for new, creative, and radical efforts to achieve the tobacco control endgame vitally important. One such effort is discussed in this PLOS Medicine Debate, where Simon Chapman presents his proposal for a “smoker's license” and Jeff Collin argues against. Chapman sets out a case for introducing a smart card license for smokers designed to limit access to tobacco products and encourage cessation. Key elements of the smoker's license include smokers setting daily limits, financial incentives for permanent license surrender, and a test of health risk knowledge for commencing smokers. Collin argues against the proposal, saying that it would shift focus away from the real vector of the epidemic—the tobacco industry—and that by focusing on individuals it would censure victims, increase stigmatization of smokers, and marginalize the poor.
Zdroje
1. DollR, PetoR, BorehamJ, SutherlandI (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328: 1519.
2. ProctorRN (2001) Tobacco and the global lung cancer epidemic. Nature 1: 82–86.
3. ChapmanS, FreemanB (2008) Markers of the denormalisation of smoking and the tobacco industry. Tob Control 17: 25–31.
4. ChapmanS, FreemanB (2010) The cancer emperor's new clothes: Australia's historic legislation for plain tobacco packaging. BMJ 340: c2436.
5. Physicians for a Smoke-Free Canada (2012) Picture based cigarette warnings. Available: http://www.smoke-free.ca/warnings/Canada-warnings.htm. Accessed 28 May 2012.
6. Framework Convention Alliance (2012) Framework Convention Alliance. Available: http://www.fctc.org/. Accessed 11 October 2012.
7. KroezenM, FranckeAL, GroenewegenPP, van DijkL (2012) Int J Nurs Stud 49: 1002–1012.
8. ChapmanS, FreemanB (2009) Regulating the tobacco retail environment: beyond reducing sales to minors. Tob Control 18: 496–501.
9. ChapmanS, LibermanJ (2005) Ensuring smokers are adequately informed: reflections on consumer rights, manufacturer responsibilities and policy implications. Tob Control 14 Suppl IIii8–ii13.
10. Laurance J (2007 October 23) Unveiled: radical prescription for our health crisis. The Independent. Available: http://www.independent.co.uk/life-style/health-and-families/health-news/unveiled-radical-prescription-for-our-health-crisis-397618.html. Accessed 28 May2012.
11. LeGrande J, Titmus R, Srivastva D (2009) Incentives for prevention. Health England report #3. Available: www.healthengland.org/publications/HealthEnglandReportNo3.pdf. Accessed 28 May 2012.
12. ChienH-Y, JanJ-K, TsengY-M (2002) An efficient and practical solution to remote authentication: smart card. Computers and Security 21: 372–375.
13. FongGT, HammondD, LauxFL, ZannaMP, CummingsKM, et al. (2004) Nicotine Tob Res 6 Suppl 3 S341–S351.
14. HylandA, BorlandR, LiQ, YongH-H, McNeillA, et al. (2006) Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control 15: iii83–iii94.
15. WilsonN, WeerasekeraD, EdwardsR, ThomsonG, DevlinM, et al. (2010) Characteristics of smoker support for increasing a dedicated tobacco tax: National survey data from New Zealand. Nicotine Tob Res 12: 168–173.
16. BorlandR, YongHH, SiahpushM, HylandA, CampbellS, et al. (2006) Support for and reported compliance with smoke-free restaurants and bars by smokers in four countries: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control Suppl 3: iii34–iii41.
17. HughesJR, CarpenterMJ (2006) Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 8: 739–749.
18. Hoek J, Maubach N, Stevenson R, Gendall P, Edwards R (2012) Social smokers' management of conflicted identities. Tob Control. Epub ahead of print 20 February 2012.
19. Cahill K, Perera R (2011) Do competitions and incentives help smokers to quit in the medium to long term? Cochrane Summaries June 15. Available: http://summaries.cochrane.org/CD004307/do-competitions-and-incentives-help-smokers-to-quit-in-the-medium-to-long-term. Accessed 28 May 2012.
20. SiahpushM, WakefieldMA, SpittalMJ, DurkinSJ, ScolloMM (2009) Taxation reduces social disparities in adult smoking prevalence. Am J Prev Med 36: 285–291.
21. Tobacco Institute of Australia (1994) Submission to Senate Community Affairs Reference Committee Inquiry into Tobacco Industry and the Costs of Tobacco-Related Illness. Sydney, Australia: Tobacco Institute of Australia.
22. KhooD, ChiamY, NgP, BerrickAJ, KoongHN (2010) Phasing-out tobacco: proposal to deny access to tobacco for those born from 2000. Tob Control 19: 355–360.
23. BellK (2011) Legislating abjection? Secondhand smoke, tobacco control policy and the public's health. Critical Public Health 21: 49–62.
24. CarterSM, ChapmanS (2006) Smokers and nonsmokers talk about regulatory options in tobacco control. Tob Control 15: 399–404.
25. Northern Territory Government. Department of Justice (2008) Licensing, regulation and alcohol strategy. June. Available: http://www.nt.gov.au/justice/licenreg/documents/liquor/fs_kath_id_system.pdf Accessed 28 May 2012.
26. South Australian Consolidated Regulations (2011) Controlled Substances (Poisons) Regulations – Reg 14. Available: http://www.austlii.edu.au/au/legis/sa/consol_reg/csr2011451/s14.html. Accessed 28 May 2012.
27. Keferl M (2009) Taspo fail – Japanese reject scarlet letter of smoking. Japan Trends. Available: http://www.japantrends.com/taspo-fail-japanese-reject-scarlet-letter-of-smoking/. Accessed 23 July 2012.
28. JoossensL, RawM (2008) Progress in combatting cigarette smuggling: controlling the supply chain. Tob Control 17: 399–404.
29. ThomsonG, EdwardsR, WilsonN, BlakelyT (2012) What are the elements of the tobacco endgame? Tob Control 21: 293–295.
30. New Zealand Government (2012) Government response to the Report of the Māori Affairs Committee on its inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Māori (final response). Available: http://smokefree.org.nz/sites/default/files/2.%20Govt%20Final%20Response%20to%20Maori%20Afairs%20Select%20Committee%20report%20-%20Mar%202011.pdf. Accessed 28 May 2012.
31. ShahabL, WestR (2010) Public support in England for a total ban on the sale of tobacco products. Tob Control 19: 143–147.
32. OakesW, ChapmanS, BalmfordJ, BorlandR, TrotterL (2004) “Bulletproof skeptics in life's jungle”: which self- exempting beliefs about smoking most predict lack of intention to quit? Prev Med 39: 776–782.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
- Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
- The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
- Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis